This text is a result of machine translation.
Beijing will carry out data collection standardization pilot in the field of digital medicine
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Medtronic's world's first self expanding pulmonary valve was first-class recalled
Research
Healthcare, Consumer Staples, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Healthcare, Technology, Consumer DiscretionaryTech for Global, Globalization Footprints of the Established and the New
Yikai capital released the first set of digital collections of Chinese investment and financing institutions
Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use
The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.
Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus
R&D of Anti-COVID-19 Drugs is Blooming in China
Anti-epidemic stocks moved higher in early trading of the Hong Kong Stock Exchange today, with Kintor Pharma-B (Chinese: 开拓药业,09939:HK) and Shandong Xinhua Pharmaceutical (Chinese: 新华制药,00719:HK) leading the rally on the back of thriving R&D of anti-coronavirus drugs.
May 17, 2022 02:15 PM
Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU
Baiyang pharmaceutical released its first annual report after listing, with double growth in revenue and net profit in 2021
Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry
TG ImmunoPharma Raises Hundreds of Mns of CNY in Pre-Series A Financing Round
TG ImmunoPharma, specializing in NK (Natural Killer) cell-based checkpoint immunotherapy drugs, is uncovering the linchpin of the next-generation method of treating cancer with the fresh funding.
May 12, 2022 06:46 PM
Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan
Hefei Tiangang immunopharmaceutical Co., Ltd., a tumor immunotherapy enterprise, completed a round of pre-A financing of hundreds of millions of yuan
The information center of the State Food and Drug Administration and Baidu Health jointly build a "national authoritative popular science platform for pharmaceutical and mechanical knowledge"
No chance for scientific innovation board! Lily medical withdrew its registration application and terminated its registration
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
Yesterday 12:51 PM